Thalidomide in Treating Patients With Myelofibrosis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of thalidomide in treating patients who have
myelofibrosis. Thalidomide may stop the growth of myelofibrosis by stopping blood flow to the
cancer cells.